Pharmaway Invest ApS: Financial statements 2020
CVR: 38585126
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Pharmaway Invest ApS (CVR 38585126) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -23,125 and a net result of DKK -25,399 compared with DKK -14,676 the year before. Equity in the 2020 report amounted to DKK 36,089,218. The solvency ratio was 99.5%.
- Gross Profit
- DKK -23,125
- Profit/Loss
- DKK -25,399
- Equity
- DKK 36,089,218
- Total Assets
- DKK 36,266,184
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -23K | -25K | 36.1M | - |
| 2019 | - | -13K | -15K | 33.8M | - |
| 2018 | - | -4K | -6K | 33.9M | - |
Official annual report
How creditworthy is Pharmaway Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Pharmaway Invest ApS has published its annual report for 2019. Gross profit came to DKK -12,500, and the net result was DKK -14,676.
About Pharmaway Invest ApS
Pharmaway Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Niels Ebbe Ebbesen. The company's owners include Ebbelykke ApS, Hundekurven ApS and Ebfos Family Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -23,125 and a net result of DKK -43,449,506 compared with DKK -38,583 the year before. Equity in the 2025 report amounted to DKK 4,538,851.
